Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2024-02-16
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Glucose:Fructose Versus Glucose Carbohydrate Ingestion and Endurance Performance
NCT02031783
Efficacy of a Carbohydrate Drink on Speed, Agility and Power in School Going Children
NCT02428127
Resistance Exercise, Recovery Drinks and Appetite
NCT02764177
Carbohydrate Mouth Rinse (Small-Sided Soccer Games)
NCT06990022
The Impact of Sucrose Ingestion During Exercise on Liver and Muscle Glycogen Concentration.
NCT02110836
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Specific Aims:
1. To examine the effect of carbohydrates delivered in different forms on running performance.
2. To examine the effect of carbohydrates delivered in different forms on physiologic measures as well as perceived exertion.
Hypotheses:
1. The investigators hypothesize that the carbohydrate-containing MR and DS will result in faster TT performance compared to a water MR (control).
2. The Investigators hypothesize that the carbohydrate-containing DS and MR will elicit higher HR and blood lactate levels (indicating greater levels of intensity) compared to control without significantly increasing RPE during the running TT.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Carbohydrate Mouth Rinse
Subjects will be instructed to complete the 12.8 km time trial (TT) as quickly as possible. They will be able to adjust the speed on the treadmill throughout the TT but will have no knowledge of what speed they are actually running at. The researcher will monitor the progress of the TT, and the completion time will be recorded. The carbohydrate mouth rinse treatment will be given just before the start of the TT and every 12.5% of the TT, but not after the completion of the TT.
Carbohydrate Mouth Rinse
Participants are provided with a carbohydrate mouth rinse for every 12.5% of the time trial that is completed (calculated based on the distance covered).
The sucrose solution will consist of 64g of sucrose dissolved in 1000 mL of water, with a bolus of 25 mL being used for each mouth rinse. Each mouth rinse solution will have 2mL of red food dye FD\&C Red No. 40 to ensure the same sensory response through appearance.
Water Mouth Rinse
Subjects will be instructed to complete the 12.8 km time trial (TT) as quickly as possible. They will be able to adjust the speed on the treadmill throughout the TT but will have no knowledge of what speed they are actually running at. The researcher will monitor the progress of the TT, and the completion time will be recorded. The water mouth rinse treatment will be given just before the start of the TT and every 12.5% of the TT, but not after the completion of the TT.
Water Mouth Rinse
Participants are provided with a water mouth rinse for every 12.5% of the time trial that is completed (calculated based on the distance covered).
The water solution will consist of 1000 mL of water, with a bolus of 25 mL being used for each mouth rinse. Each mouth rinse solution will have 2mL of red food dye FD\&C Red No. 40 to ensure the same sensory response through appearance.
Carbohydrate Dissolvable Strip
Subjects will be instructed to complete the 12.8 km time trial (TT) as quickly as possible. They will be able to adjust the speed on the treadmill throughout the TT but will have no knowledge of what speed they are actually running at. The researcher will monitor the progress of the TT, and the completion time will be recorded. The carbohydrate dissolvable strip treatment will be given just before the start of the TT and every 12.5% of the TT, but not after the completion of the TT.
Carbohydrate Dissolvable Strip
Participants are provided with a carbohydrate dissolvable strip for every 12.5% of the time trial that is completed (calculated based on the distance covered).
The carbohydrate dissolvable strip (Innsol Health Corp.) is primarily composed of sucrose and glucose; however, the full ingredient list includes pullulan, mannitol, menthol, hydroxyl propyl methyl cellulose, eucalyptol, polysorbate 80, glyceryl oleate, purified water.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Carbohydrate Dissolvable Strip
Participants are provided with a carbohydrate dissolvable strip for every 12.5% of the time trial that is completed (calculated based on the distance covered).
The carbohydrate dissolvable strip (Innsol Health Corp.) is primarily composed of sucrose and glucose; however, the full ingredient list includes pullulan, mannitol, menthol, hydroxyl propyl methyl cellulose, eucalyptol, polysorbate 80, glyceryl oleate, purified water.
Carbohydrate Mouth Rinse
Participants are provided with a carbohydrate mouth rinse for every 12.5% of the time trial that is completed (calculated based on the distance covered).
The sucrose solution will consist of 64g of sucrose dissolved in 1000 mL of water, with a bolus of 25 mL being used for each mouth rinse. Each mouth rinse solution will have 2mL of red food dye FD\&C Red No. 40 to ensure the same sensory response through appearance.
Water Mouth Rinse
Participants are provided with a water mouth rinse for every 12.5% of the time trial that is completed (calculated based on the distance covered).
The water solution will consist of 1000 mL of water, with a bolus of 25 mL being used for each mouth rinse. Each mouth rinse solution will have 2mL of red food dye FD\&C Red No. 40 to ensure the same sensory response through appearance.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or Female
* Normal body mass index (BMI) between 18.0-24.9kg/m2
* All subjects will be endurance-trained athletes who participate in training on a regular basis (≥4 sessions per week for at least 1 hour per session of aerobic/endurance exercise (such as running, cycling, or swimming)
* Women will be tested only during the follicular phase of their menstrual cycle (days 2-9) to control for any fluctuation in hormones
* Individuals aged 35 or older must pass the Physical Activity Readiness Questionnaire (PARQ2)
Exclusion Criteria
* Changes in current exercise program
* Chronic diseases (including but not limited to type II diabetes, hypertension, hypotension, hyperthyroidism, cardiovascular disease, and cancer)
* Medications that could alter metabolic rate or hydration status
* Supplement use other than fish oil or vitamin/mineral supplements
* Nicotine use
* Pregnancy or nursing
* Donation of blood in the 20 days prior to testing
* A failing result on the Physical Activity Readiness Questionnaire (PARQ2) for those aged 35 or older
* Allergy to red food dye FD\&C Red No. 40
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Georgia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jamie Cooper, PhD
Professor and Department Head
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jamie A Cooper, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Georgia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Georgia
Athens, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PROJECT00005235
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.